These findings suggest that the pharmacologic actions of ginsenoside Re to improve isoproterenol-induced myocardial fibrosis and heart failure were associated (at least in part) with regulation of the TGF-β1/Smad3 pathway. This evidence concerns the gene TGFB1 and Myocardial fibrosis.